-1%
Dulaglutide, 0.75mg/0.5ml, can be utilized as a monotherapy when diet and exercise alone fail to achieve adequate blood sugar control in patients for whom metformin is not suitable. Additionally, it can be used as an adjunct therapy with other glucose-lowering medications if necessary.
Trulicity contains Dulaglutide, which belongs to a group of medicines called Incretin mimetics. It is used to manage type II diabetes mellitus along with diet and exercise. Type 2 diabetes is a condition in which the body does not produce enough insulin, and the insulin that is produced does not work as effectively as it should. This leads to an accumulation of sugar (glucose) in the blood.
GLP-1, the active component in Trulicity, stimulates the pancreas to produce more insulin after meals, helping to regulate blood glucose levels within the normal range. It facilitates the release of the right amount of insulin when blood sugar levels are elevated. Insulin, in turn, aids in moving sugar from the blood into other body tissues where it is utilized for energy.
Always use this medicine as prescribed by your doctor. It is not recommended for children and adolescents under 18 years of age, as well as for patients with severe stomach or intestinal problems. Pregnant or breastfeeding women and those trying to conceive should not take Trulicity. Consult your doctor for guidance.
The most common side effects include nausea, diarrhea, vomiting, decreased appetite, and indigestion. If any of these side effects worsen or persist for an extended period, consult your doctor.